Cleared Traditional

K871231 - ANTIBODY ASSAY FOR DETECTION OF INFLUENZA B
(FDA 510(k) Clearance)

K871231 · Microscan Div. Baxter Healthcare Corp. · Microbiology
Jun 1987
Decision
91d
Days
Class 1
Risk

K871231 is an FDA 510(k) clearance for the ANTIBODY ASSAY FOR DETECTION OF INFLUENZA B. This device is classified as a Antigens, Cf (including Cf Control), Influenza Virus A, B, C (Class I — General Controls, product code GNX).

Submitted by Microscan Div. Baxter Healthcare Corp. (West Sacramento, US). The FDA issued a Cleared decision on June 26, 1987, 91 days after receiving the submission on March 27, 1987.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3330.

Submission Details

510(k) Number K871231 FDA.gov
FDA Decision Cleared SESE
Date Received March 27, 1987
Decision Date June 26, 1987
Days to Decision 91 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary

Device Classification

Product Code GNX — Antigens, Cf (including Cf Control), Influenza Virus A, B, C
Device Class Class I — General Controls
CFR Regulation 21 CFR 866.3330

Similar Devices — GNX Antigens, Cf (including Cf Control), Influenza Virus A, B, C

All 17
ALERE BINAXNOW INFLUENZA A & B CARD
K133411 · Alere Scarborough, Inc D/B/A Binax, Inc. · Dec 2013
SAS FLUALERT A & B, SAS INFLUENZA A TEST
K132352 · Sa Scientific , Ltd. · Aug 2013
REMEL XPECT FLU A&B
K131804 · Remel, Inc. · Jul 2013
QUICK VUE INFLUENZA
K131599 · Quidel Corporation · Jul 2013
SOFIA INFLUENZA A+B FIA
K131606 · Quidel Corp. · Jul 2013
QUICKVUE INFLUENZA A+B
K131619 · Quidel Corp. · Jun 2013